Cleary Gottlieb advised Surescripts, while Kirkland & Ellis advised TPG on the transaction. Surescripts, a leading health information network, announced its strategic partnership with TPG Capital,...
You must be a Standard 1 Year member to access this content.
Hamilton Locke advised Tryptamine Therapeutics Limited on the deal. Tryptamine Therapeutics Limited secured the acquisition and backdoor listing of Tryp Therapeutics Inc., a biotechnology entity previously...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton is representing Synopsys, while Skadden and Goodwin Procter are representing ANSYS on the deal. Synopsys, Inc. (Synopsys) announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb represented Sysco Corporation in the transaction. Sysco Corporation (Sysco; NYSE:SYY) has agreed to acquire Edward Don & Company (DON). The transaction was announced on October...
You must be a Standard 1 Year member to access this content.
Hamilton Locke advised AuTECO Minerals Ltd on the deal. AuTECO Minerals Ltd proposed a A$65 million acquisition of the Green Bay Copper-Gold Project in Newfoundland, Canada and associated...
You must be a Standard 1 Year member to access this content.
Hamilton Locke advised Cleo Diagnostics Ltd on the offering. Cleo Diagnostics Ltd completed a successful initial public offering and recent listing on the ASX. The IPO raised...
You must be a Standard 1 Year member to access this content.
Hamilton Locke have advised Dynamic Group Holdings Ltd (ASX: DDB) on its agreement to acquire 100% of Welldrill. Sternship Advisers acted as financial adviser. The acquisition...
You must be a Standard 1 Year member to access this content.
Hamilton Locke acted for Bellavista Resources Ltd on its successful initial public offering. Bellavista Resources Ltd closed its $6.5 million initial public offering on the ASX under the ticker...
You must be a Standard 1 Year member to access this content.
